P Stephen Squinto
Affiliations
- Large Shareholder, Director at Springworks Therapeutics Inc. (SWTX), 2022-05-20
- Director at Compass Therapeutics Inc. (CMPX), 2022-02-23
- Director at Chemomab Therapeutics Ltd. (CMMB), 2021-04-21
- Head Of Research And Dev at Passage Bio Inc. (PASG), 2020-03-02
- Director at Audentes Therapeutics Inc. (BOLD), 2017-10-10
- Evp, Chief Global Ops. Officer at Alexion Pharmaceuticals Inc (ALXN), 2014-10-28
Insider Trading: Purchases See All
| Symbol | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| SWTX | $18.00 | 275,000 | $4,950,000.00 | 7,406,307 | 2019-09-17 | Filing |
Insider Trading: Sales See All
| Symbol | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| SWTX | $76.20 | 19,231 | $1,465,436.82 | 125,728 | 2021-04-28 | Filing |
| SWTX | $75.05 | 201 | $15,085.01 | 144,959 | 2021-04-27 | Filing |
| SWTX | $75.01 | 1,057 | $79,290.54 | 145,160 | 2021-04-15 | Filing |
| SWTX | $75.08 | 511 | $38,364.50 | 146,217 | 2021-04-14 | Filing |
| ALXN | $189.00 | 2,069 | $391,041.00 | 106,508 | 2014-10-27 | Filing |